Author

R. Olfati-Saber

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Bioengineering· 1 Cell Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:deep learning· 2 Research Focus:cell-cell communication· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Research Focus:gene regulatory network inference· 1 Organism:human· 1 Assay:proteomics· 1 Assay:scRNA-seq· 1

Frequent Co-Authors

A. Kurlovs· 1 shared A. Masiero· 1 shared A. Park· 1 shared C. Prades· 1 shared E. de Rinaldis· 1 shared F. Auge· 1 shared F. Rapaport· 1 shared J. H. Lee· 1 shared

Activity by Year

2021-2022 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 20 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCell Biology

A. Kurlovs

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

DiSiR: a software framework to identify ligand-receptor interactions at subunit level from single-cell RNA-sequencing data

M. Rafiee Vahid, A. Kurlovs, F. Auge, R. Olfati-Saber, E. de Rinaldis, F. Rapaport, V. Savova

DiSiR identifies ligand-receptor interactions at the subunit level from scRNA-seq data, outperforming existing methods in inferring disease-related pathways.

bioRxiv · Mar 25, 2022 · PreprintCell Biology

Application of an integrated computational antibody engineering platform to design SARS-CoV-2 neutralizers

S. Riahi, J. H. Lee, S. Wei, R. Cost, A. Masiero, C. Prades, R. Olfati-Saber, M. Wendt, A. Park, Y. Qiu, Y. Zhou

The paper designs SARS-CoV-2 neutralizing antibodies using a computational platform to improve binding affinity and developability, and introduces trispecific formats and Fc modifications to enhance efficacy and reduce risk.

bioRxiv · Mar 23, 2021Bioengineering